missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Anticuerpos
  4. Anticuerpos primarios
  5. Todos los anticuerpos primarios
  6. 18208172

CD19 Antibody (CVID3/155), DyLight 350, Novus Biologicals™

Código de producto. 18208172 Tienda Bio Techne Productos
Change view
Click to view available options
Cantidad:
0.1 mL
Tamaño de la unidad:
0.10 ml
Código de producto. Cantidad unitSize
18208172 0.1 mL 0.10 ml
1 options
Este artículo no se puede devolver. Vea la política de devoluciones

Código de producto. 18208172

Marca: Novus Biologicals NBP261908UV

Por favor, para comprar este producto. ¿No tiene usuario web? Regístrese hoy mismo.

Este artículo no se puede devolver. Vea la política de devoluciones

Descripción

Mouse Monoclonal Antibody

CD19 Monoclonal specifically detects CD19 in Human, Monkey samples. It is validated for Flow Cytometry, Immunocytochemistry/Immunofluorescence.
TRUSTED_SUSTAINABILITY

Especificaciones

Antígeno CD19
Aplicaciones Flow Cytometry, Immunocytochemistry, Immunofluorescence
Clasificación Monoclonal
Clon CVID3/155
Conjugado DyLight 350
Dilución Flow Cytometry, Immunocytochemistry/Immunofluorescence
Formulación 50mM Sodium Borate with 0.05% Sodium Azide
Alias de gen B4, B-lymphocyte antigen CD19, B-lymphocyte surface antigen B4, CD19 antigen, CD19 molecule, CVID3, Differentiation antigen CD19, MGC12802, T-cell surface antigen Leu-12
Símbolos de los genes CD19
Especie del huésped Mouse
Inmunógeno Recombinant full-length human CD19 protein (Uniprot: P15391 )
Método de purificación Protein A or G purified
Cantidad 0.1 mL
Disciplina de investigación Adaptive Immunity, B Cell Development and Differentiation Markers, Cytokine Research, Immunology, Innate Immunity, Mesenchymal Stem Cell Markers, Myeloid derived Suppressor Cell, Signal Transduction, Stem Cell Lines, Stem Cell Markers
Primario o secundario Primary
ID de gen (Entrez) 930
Especificidad de la prueba Recognizes a protein of 95kDa, identified as CD19. CD19 is a transmembrane glycoprotein that contains two extracellular immunoglobulin-like domains. CD19 is present in both benign and malignant B-cells and is considered to be the most reliable surface marker of this lineage over a wide range of maturational stages. In normal lymphoid tissue, CD19 is observed in germinal centers, in mantle zone cells, and in scattered cells of the inter-follicular areas. Anti-CD19 exhibits an overall immunoreactivity pattern similar to those of the antibodies against CD20 and CD22. However, in contrast to CD20, expression of CD19 is continuous throughout B-cell development and through terminal differentiation of B-cells into plasma cells. Anti-CD19 positivity is seen in the vast majority of B-cell neoplasms commonly at a lower intensity than normal B-cell counterparts. Plasma cell neoplasms are nearly always negative, as are T-cell neoplasms.
Especies diana Human, Monkey
Contenido y almacenamiento Store at 4°C in the dark.
Isotype IgG1 κ
Mostrar más Mostrar menos
Título del producto
Seleccione un problema

Al hacer clic en Enviar, acepta que Fisher Scientific se ponga en contacto con usted en relación con los comentarios que ha proporcionado en este formulario. No compartiremos su información para ningún otro fin. Toda la información de contacto proporcionada se mantendrá de acuerdo con nuestra Política de Privacidad. Política de privacidad.